Brief: Us FDA Approves Spectral Medical’S Protocol Amendment For Tigris
10/08/2020 13:58
Spectral Medical Inc EDT.TO :
* US FDA APPROVES SPECTRAL MEDICAL’S PROTOCOL AMENDMENT FOR
TIGRIS
* SPECTRAL MEDICAL - PROTOCOL AMENDMENT ALLOWS FOR INCREASE
IN
TIGRIS SITES TO 15 WHILE POTENTIALLY ACCELERATING PATIENT
ENROLLING
Source text for Eikon: ID:nGNXbQ8GV6
Further company coverage: EDT.TO
Recent news on Spectral Medical
See all newsBrief: Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting For PMX PMA
Canada's Spectral Medical Q2 revenue falls on lower reagent sales
Brief: Spectral Medical And Vantive Announce Topline 12 Month Follow-Up Results From Spectral’S Tigris Trial
Canada's Spectral Medical Q1 revenue rises 56%, net loss narrows
Spectral Medical Q3 revenue up 34%